Kyungdong Pharm banner
K

Kyungdong Pharm
KOSDAQ:011040

Watchlist Manager
Kyungdong Pharm
KOSDAQ:011040
Watchlist
Price: 5 630 KRW 1.26% Market Closed
Market Cap: ₩173.2B

Kyungdong Pharm
Change in Working Capital

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Kyungdong Pharm
Change in Working Capital Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Change in Working Capital CAGR 3Y CAGR 5Y CAGR 10Y
K
Kyungdong Pharm
KOSDAQ:011040
Change in Working Capital
₩6.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Yuhan Corp
KRX:000100
Change in Working Capital
-₩109B
CAGR 3-Years
-38%
CAGR 5-Years
4%
CAGR 10-Years
-23%
SK Biopharmaceuticals Co Ltd
KRX:326030
Change in Working Capital
-₩55.8B
CAGR 3-Years
7%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Change in Working Capital
-₩212.2B
CAGR 3-Years
-24%
CAGR 5-Years
N/A
CAGR 10-Years
-2%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Change in Working Capital
-₩17B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
C
Caregen Co Ltd
KOSDAQ:214370
Change in Working Capital
-₩21.9B
CAGR 3-Years
32%
CAGR 5-Years
-27%
CAGR 10-Years
N/A
No Stocks Found

Kyungdong Pharm
Glance View

Market Cap
173.2B KRW
Industry
Pharmaceuticals

KYUNG DONG PHARMACEUTICAL Co., Ltd. engages in the manufacture and sale of medicines for liver therapy, gastrointestinal, antimigrain, osteoporosis, cardiovascular, antiviral, antiobesity, muscle relaxant, neuropathic, antibacterial, antidiabetic, central nervous system, antifungal, urology, antispasmodic, pain and inflammation, antihistamine, vitamin, repiratory, antiinflammatory enzyme, respiratory and others. The company is headquartered in Hwaseong, Gyeonggi-Do. is a Korea-based company engaged in the manufacture and marketing of pharmaceutical products. The Company’s products include liver therapies, gastrointestinal drugs, antimigraine drugs, antiviral, anti-obesity medications, antibacterial drugs, antidiabetic drugs, antifungal, allergy medications, antispasmodics, antihistamines, vitamins, as well as drugs for osteoporosis, cardiovascular, muscle relaxant, neuropathic and other diseases. The company also provides various over-the-counter (OTC) drugs, such as anti-inflammatory medicines, antiviral drugs, antihistamine drugs, gastrointestinal drugs and others. In addition, the Company engages in the leasing of real estate, and distribution of snowboards and health functional food.

Intrinsic Value
5 650.66 KRW
Fairly Valued
Intrinsic Value
Price ₩5 630
K

See Also

What is Kyungdong Pharm's Change in Working Capital?
Change in Working Capital
6.8B KRW

Based on the financial report for Sep 30, 2025, Kyungdong Pharm's Change in Working Capital amounts to 6.8B KRW.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett